Seminars in Oncology
Volume 36, Issue 6 , Pages 542-552 , December 2009

Human Papilloma Virus and Female Lung Adenocarcinoma

  • Yao-Jen Li

      Affiliations

    • Genomics Research Center, Academia Sinica. Tapei, Taiwan
    • Graduate Institute of Epidemiology, National Taiwan University, Taipei, Taiwan
    • ,
  • Yu-Chin Tsai

      Affiliations

    • Genomics Research Center, Academia Sinica. Tapei, Taiwan
    • ,
  • Yen-Ching Chen

      Affiliations

    • Institute of Preventive Medicine and Research Center for Gene, Environment, and Human Health, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationAddress correspondence to Yen-Ching Chen, No. 17 Xu-Shou Rd, Taipei, 10020 Taiwan
    • ,
  • David C. Christiani

      Affiliations

    • Environmental and Occupational Medicine and Epidemiology Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA
    • Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA
    • Corresponding Author InformationDavid C. Christiani, 665 Huntington Ave, Bldg I, Room 1407, Boston, MA 02115

References 

  1. Parkin DM, Pisani P, Ferly J. Estimate of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606
  2. Shephard RJ. Aging, physical activity, and health. Champaign, IL: Human Kinetics; 1997;
  3. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001;31:123–137
  4. In: Taipei, Taiwan: Taiwan Cancer Registry; 2005;p. 52–53
  5. Cha Q, Chen YZ, Du YX. The trends in histological types of lung cancer during 1980-1988, Guangzhou, China. Lung Cancer. 1997;17:219–230
  6. Lam KY, Fu KH, Wong MP, Wang EP. Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology. 1993;25:103–105
  7. Watanabe S, Tsugane S, Arimoto H, et al. Trend of lung cancers in the National Cancer Center of Japan and comparison with that of Japanese pathological autopsy records. Jpn J Cancer Res. 1987;78:460–466
  8. Ikeda T, Kurita Y, Inutsuka S, et al. The changing pattern of lung cancer by histological type—a review of 1151 cases from a university hospital in Japan, 1970-1989. Lung Cancer. 1991;7:157–164
  9. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123:21S–49S
  10. Liao ML, Chen ZW, Zheng Y, et al. Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations. Zhonghua Yi Xue Za Zhi. 2007;87:1876–1880
  11. Song FJ, He M, Li HX, et al. A cancer incidence survey in Tianjin: the third largest city in China—between 1981 and 2000. Cancer Causes Control. 2008;19:443–450
  12. Koo LC, Ho JH. Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol. 1990;19:S14–S23
  13. Ko YC, Lee CH, Chen MJ, et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol. 1997;26:24–31
  14. Yang SP, Luh KT, Kuo SH, Lin CC. Chronological observation of epidemiological characteristics of lung cancer in taiwan with etiological consideration—a 30-year consecutive study. Jpn J Clin Oncol. 1984;14:7–19
  15. Rachtan J. Smoking, passive smoking and lung cancer cell types among women in Poland. Lung Cancer. 2002;35:129–136
  16. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CWJ. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89:1580–1586
  17. Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res. 1999;59:4570–4573
  18. Pershagen G, Akerblom G, Axelson O, et al. Residential radon exposure and lung cancer in Sweden. N Engl J Med. 1994;330:159–164
  19. Pope CAr, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995;151:669–674
  20. Wu-Williams AH, Dai XD, Blot W, et al. Lung cancer among women in north-east China. Br J Cancer. 1990;62:982–987
  21. Ko YC, Cheng LS, Lee CH, et al. Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol. 2000;151:140–147
  22. Metayer C, Wang Z, Kleinerman RA, et al. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer. 2002;35:111–117
  23. Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H. The increasing incidence of lung adenocarcinoma: reality or artifact? (A review of the epidemiology of lung adenocarcinoma). Int J Epidemiol. 1997;26:14–23
  24. Takezaki T, Hirose K, Inoue M, et al. Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer. 2001;84:1199–1206
  25. De Stefani E, Brennan P, Boffetta P, et al. Diet and adenocarcinoma of the lung: a case-control study in Uruguay. Lung Cancer. 2002;35:43–51
  26. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93:825–833
  27. Chen KY, Hsiao CF, Chang GC, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer. 2007;110:1768–1775
  28. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005;65:1598–1605
  29. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 2007;28:507–518
  30. Alavanja MC, Brownson RC, Boice JD, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992;136:623–632
  31. Zheng W, Blot WJ, Liao ML, et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer. 1987;56:501–504
  32. Omoto Y, Kobayashi Y, Nishida K, et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun. 2001;285:340–347
  33. Alì G, Donati V, Loggini B, et al. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol. 2008;39:1465–1473
  34. Jou YS, Lo YL, Hsiao CF, et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients. Lung Cancer. 2009;64:251–256
  35. Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61:2799–2803
  36. Syrjänen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55:885–891
  37. Syrjänen KJ. Condylomatous changes in neoplastic bronchial epithelium (Report of a case). Respiration. 1979;38:299–304
  38. Chiou HL, Wu MF, Liaw YC, et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer. 2003;97:1558–1563
  39. Wang Y, Wang A, Jiang R, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep. 2008;20:333–339
  40. Prendiville W, Davies P. The health professional's HPV handbook. London: Taylor & Francis; 2005;
  41. Brown DR, Fan L, Jones J, Bryan J. Colocalization of human papillomavirus type 11 E1 E4 and L1 proteins in human foreskin implants grown in athymic mice. Virology. 1994;201:46–54
  42. Doorbar J, Ely S, Sterling J, McLean C, Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 1991;352:824–827
  43. Valle GF, Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J Gen Virol. 1995;76:1239–1245
  44. Garcea RL, DiMaio D. The papillomaviruses. New York: Springer; 2007;
  45. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350
  46. Sun Y, Hildesheim A, Brinton LA, et al. Human papillomavirus-specific serologic response in vulvar neoplasia. Gynecol Oncol. 1996;63:200–203
  47. Zumbach K, Hoffmann M, Kahn T, et al. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer. 2000;85:815–818
  48. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–698
  49. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109:542–547
  50. Sur M, Cooper K. The role of the human papilloma virus in esophageal cancer. Pathology. 1998;30:348–354
  51. Bhawal UK, Sugiyama M, Nomura Y, Kuniyasu H, Tsukinoki K. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008;134:1055–1059
  52. Scheckenbach K, Lieven O, Götte K, et al. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004;131:1805–1809
  53. Cheng YW, Wu MF, Wang J, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res. 2007;67:10686–10693
  54. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992;136:54–58
  55. Frisch M, Melbye M. Risk of lung cancer in pre- and post-menopausal women with ano-genital malignancies. Int J Cancer. 1995;62:508–511
  56. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108:766–772
  57. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265
  58. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metast Rev. 1996;15:91–112
  59. Aguayo F, Castillo A, Koriyama C, et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer. 2007;97:85–91
  60. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol. 2006;44:1755–1762
  61. Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Göran Hansson B, Andersson G. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005;125:1327–1336
  62. Hansson BG, Rosenquist K, Antonsson A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005;125:1337–1344
  63. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–1956
  64. Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res. 1999;59:753–757
  65. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull. 2002;49:194–209
  66. van der Snoek EM, Niesters HG, Mulder PG, van Doornum GJ, Osterhaus AD, van der Meijden WI. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003;30:639–644
  67. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004;190:2070–2076
  68. Pao CC, Lin SS, Lin CY, Maa JS, Lai CH, Hsieh TT. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol. 1991;95:540–546
  69. Liu VW, Tsang P, Yip A, Ng TY, Wong LC, Ngan HY. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol. 2001;82:269–272
  70. Dong SM, Pai SI, Rha SH, et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev. 2002;11:3–6
  71. Tseng CJ, Pao CC, Lin JD, Soong YK, Hong JH, Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol. 1999;17:1391–1396
  72. Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM. Could human papillomaviruses be spread through blood?. J Clin Microbiol. 2005;43:5428–5434
  73. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90:1626–1636
  74. Syrjänen KJ, Chang F, Syrjänen SM. HPV infections in etiology of benign and malignant sinonasal, bronchial and oesophageal squamous cell lesions. In:  Monsonego J editors. Fourth International Multidisciplinary Congress EUROGIN 2000 (Paris, April 5-9, 2000). Bologna: Monduzzi Editore; 2000;p. 169–179
  75. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003;31:57–65
  76. Chen HB, Chen L, Zhang JK, et al. Human papillomavirus 16 E6 is associated with the nuclear matrix of esophageal carcinoma cells. World J Gastroenterol. 2001;7:788–791
  77. Han C, Qiao G, Hubbert NL, et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst. 1996;88:1467–1471
  78. Bjørge T, Hakulinen T, Engeland A, et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 1997;57:3989–3992
  79. Lagergren J, Wang Z, Bergström R, Dillner J, Nyrén O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst. 1999;91:156–162
  80. Lehtinen M, Pawlita M, Zumbach K, et al. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol. 2003;188:49–55
  81. Syrjanen K, Syrjanen S. HPV infection in the respiratory tract (Papillomavirus infections in human pathology). In: New York: Wiley; 2000;p. 355–378
  82. Kashima HK, Mounts P. Tumors of the head and neck, larynx, lung andesophagus and their possible relation to HPV (Papillomaviruses and human disease). In: Heidelberg: Springer-Verlag; 1987;p. 138–157
  83. Franzmann MB, Buchwald C, Larsen P, Balle V. Tracheobronchial involvement of laryngeal papillomatosis at onset. J Laryngol Otol. 1994;108:164–165
  84. Wilde E, Duggan MA, Field SK. Bronchogenic squamous cell carcinoma complicating localized recurrent respiratory papillomatosis. Chest. 1994;105:1887–1888
  85. Schiffman MH, Bauer HM, Lorincz AT, et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol. 1991;29:573–577
  86. Schiffman MH. Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. IARC Sci Publ. 1992;119:169–179
  87. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol. 1998;11:971–977
  88. Qureshi MN, Mansukhani M, Layfield L, McGleenon RC, Ringer P, Rudelli RD. Comparison of HC IIT, InformT HPV and PCR methodologies in diagnosing high risk and low risk types of HPV: evaluation of predictive value and crossreactivity. Acta Cytol. 2002;46:927
  89. Caussy D, Orr W, Daya AD, Roth P, Reeves W, Rawls W. Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens. J Clin Microbiol. 1998;26:236–243
  90. Pao CC, Hor JJ, Yang FP, Lin CY, Tseng CJ. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol. 1997;15:1008–1012
  91. Ho CM, Yang SS, Chien TY, Huang SH, Jeng CJ, Chang SF. Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol. 2005;99:615–621
  92. Jacobs MV, Walboomers JM, van Beek J, et al. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer. 1999;81:114–121
  93. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer. 1995;72:412–417
  94. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357–361
  95. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153:1731–1739
  96. Furuta Y, Takasu T, Asai T, et al. Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction. Cancer. 1992;69:353–357
  97. Farthing A, Masterson P, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol. 1994;47:649–652
  98. Gravitt PE, Peyton CL, Apple RJ. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. C.M. W. J Clin Microbiol. 1998;36:3020–3027
  99. Cuschieri KS, Whitley MJ, Cubie HA. Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring. J Med Virol. 2004;73:65–70
  100. Molden T, Kraus I, Skomedal H, Nordstrøm T, Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods. 2007;142:204–212
  101. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. 1995;69:2989–2997
  102. Lörincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am. 1996;23:707–730
  103. Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett. 2003;198:187–192
  104. Monsonego J, Bohbot JM, Pollini G, et al. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol. 2005;99:160–168
  105. Lin CY, Chen HC, Lin RW, et al. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods. 2007;140:1–9
  106. Chow VT, Loh E, Yeo WM, Tan SY, Chan R. Identification of multiple genital HPV types and sequence variants by consensus and nested type-specific PCR coupled with cycle sequencing. Pathology. 2000;32:204–208
  107. Feoli-Fonseca JC, Oligny LL, Brochu P, Simard P, Falconi S, Yotov WV. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol. 2001;63:284–292
  108. Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2189–2193
  109. Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002;40:886–891
  110. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503–517
  111. Sharp PA, Berk AJ, Berget SM. Transcription maps of adenovirus. Methods Enzymol. 1980;65:750–768
  112. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986–994
  113. Kinoshita I, Dosaka-Akita H, Shindoh M, et al. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer. 1995;71:344–349
  114. Li Q, Hu K, Pan X, Cao Z, Yang J, Hu S. Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J (Engl). 1995;108:610–614
  115. Da J, Chen L, Hu Y. Human papillomavirus infection and p53 gene mutation in primary lung cancer. Zhonghua Zhong Liu Za Zhi. 1996;18:27–29
  116. Soini Y, Nuorva K, Kamel D, et al. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax. 1996;51:887–893
  117. Miyagi J, Kinjo T, Tsuhako K, et al. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology. 2001;38:355–367
  118. Clavel CE, Nawrocki B, Bosseaux B, et al. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer. 2000;88:1347–1352
  119. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol. 2005;18:1606–1609
  120. Brink AA, Snijders PJ, Meijer CJ. HPV detection methods. Dis Markers. 2007;23:273–281
  121. Nobbenhuis MA, Meijer CJ, van den Brule AJ, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer. 2001;84:796–801
  122. Guerrero E, Daniel RW, Bosch FX, et al. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol. 1992;30:2951–2959
  123. Clavel C, Masure M, Putaud I, et al. Hybrid capture II, a new sensitive test for human papillomavirus detection (Comparison with hybrid capture I and PCR results in cervical lesions). J Clin Pathol. 1998;51:737–740

PII: S0093-7754(09)00182-1

doi: 10.1053/j.seminoncol.2009.10.002

Seminars in Oncology
Volume 36, Issue 6 , Pages 542-552 , December 2009

Article Tools

* Image Usage & Resolution